Sidley Represents Lumexa Imaging in US$462.5 Million Initial Public Offering

Sidley represented Lumexa Imaging Holdings, Inc. in its initial public offering of 25,000,000 shares of its common stock, par value US$0.001 per share (the “Common Stock”), at a price to the public of US$18.50 per share of Common Stock. In connection with the offering, Lumexa Imaging has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Common Stock. The Common Stock will begin trading on the Nasdaq Global Select Market under the symbol “LMRI” on December 11, 2025, and the offering is expected to close on December 12, 2025.

The Sidley deal team was led by Sam Gandhi, Alex Csordas, and Kayla West (Capital Markets) and Anthony Norris (M&A and Private Equity), and included Katherine Walsh, Julia Gaul, and Christine Seo (law clerk) (Capital Markets); Rachel Kleinberg and Jonathan Westreich (Tax); Corey Perry and Ryan McLeod (Employee Benefits and Executive Compensation); Katie Klaben and Yunzhou Wang (Securities Enforcement and Regulatory); Chad Ehrenkranz and George Maliha (Healthcare); and Maureen Crough and Nicole Noëlliste (Environmental, Health, and Safety).